Ledger.Open graph →
SEC Form D · filed July 26, 2022

Swing Therapeutics, Inc

Offering
$12.5M
Sold
$10.3M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SAN FRANCISCO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

Zack Lynch · San Francisco, CADirectorMichael Rosenbluth · San Francisco, CAExec · DirectorAndrew Firlik · San Francisco, CADirectorDavid Robinson · LAS VEGAS, NVExec · DirectorChristopher Winiarz · LAS VEGAS, NVDirectorPuja B. Khanna · Las Vegas, NVDirectorClayton Degiacinto · Grand Cayman, Cayman IslandsExec · DirectorMitchell J. Glass · BALTIMORE, MDDirectorWendy Beer · Grand Cayman, Cayman IslandsDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗